Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization

The Covid-19 pandemic has ravaged the globe, and its causative agent, SARS-CoV-2, continues to rage. Prospects of ending this pandemic rest on the development of effective interventions. Two monoclonal antibody (mAb) therapeutics have received emergency use authorization(1,2), and more are in the pi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Res Sq
Main Authors: Wang, Pengfei, Liu, Lihong, Iketani, Sho, Luo, Yang, Guo, Yicheng, Wang, Maple, Yu, Jian, Zhang, Baoshan, Kwong, Peter D., Graham, Barney S., Mascola, John R., Chang, Jennifer Y., Yin, Michael T., Sobieszczyk, Magdalena, Kyratsous, Christos A., Shapiro, Lawrence, Sheng, Zizhang, Nair, Manoj S., Huang, Yaoxing, Ho, David D.
Format: Artigo
Sprog:Inglês
Udgivet: American Journal Experts 2021
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7852232/
https://ncbi.nlm.nih.gov/pubmed/33532763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-155394/v1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker